HEADER SIGNALING PROTEIN 28-MAR-22 7UI5 TITLE EVOLUTION AVOIDS A PATHOLOGICAL STABILIZING INTERACTION IN THE IMMUNE TITLE 2 PROTEIN S100A9 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN S100-A9; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CALGRANULIN-B,CALPROTECTIN L1H SUBUNIT,LEUKOCYTE L1 COMPLEX COMPND 5 HEAVY CHAIN,MIGRATION INHIBITORY FACTOR-RELATED PROTEIN 14,MRP-14, COMPND 6 P14,S100 CALCIUM-BINDING PROTEIN A9; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: S100A9, CAGB, CFAG, MRP14; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PET; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PETDUET-1 KEYWDS S100A9; CALCIUM BINDING; S100; SIGNALING, SIGNALING PROTEIN EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR P.N.REARDON,J.L.HARMAN,S.M.COSTELLO,G.D.WARREN,S.R.PHILLIPS, AUTHOR 2 P.J.CONNOR,S.MARQUSEE,M.J.HARMS REVDAT 2 15-MAY-24 7UI5 1 REMARK REVDAT 1 26-OCT-22 7UI5 0 JRNL AUTH J.L.HARMAN,P.N.REARDON,S.M.COSTELLO,G.D.WARREN,S.R.PHILLIPS, JRNL AUTH 2 P.J.CONNOR,S.MARQUSEE,M.J.HARMS JRNL TITL EVOLUTION AVOIDS A PATHOLOGICAL STABILIZING INTERACTION IN JRNL TITL 2 THE IMMUNE PROTEIN S100A9. JRNL REF PROC.NATL.ACAD.SCI.USA V. 119 29119 2022 JRNL REFN ESSN 1091-6490 JRNL PMID 36194634 JRNL DOI 10.1073/PNAS.2208029119 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7UI5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-MAR-22. REMARK 100 THE DEPOSITION ID IS D_1000263658. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.4 REMARK 210 IONIC STRENGTH : 110 REMARK 210 PRESSURE : 1.01 BAR REMARK 210 SAMPLE CONTENTS : 25 MM TRIS, 100 MM SODIUM REMARK 210 CHLORIDE, 10 MM CALCIUM CHLORIDE, REMARK 210 1 MM [U-100% 13C; U-100% 15N] REMARK 210 S100A9-M63F, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 3D HNCA; 3D HNCACB; 3D HNCO; 3D REMARK 210 HN(CA)CO; HN(CO)CACB; 3D 1H-13C REMARK 210 1H-15N NOESY; 3D HNHA; 2D HDCB; REMARK 210 2D HECB; 3D HCCH-TOCSY; 3D CCH- REMARK 210 TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III HD REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE, NMRVIEW REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 3 -87.35 61.98 REMARK 500 1 HIS A 104 -167.17 56.89 REMARK 500 1 SER B 90 78.47 63.98 REMARK 500 1 HIS B 104 -137.50 50.98 REMARK 500 2 LEU A 45 49.98 -84.63 REMARK 500 2 LEU B 45 49.66 -84.02 REMARK 500 2 LYS B 93 -162.07 38.66 REMARK 500 3 LEU A 45 55.90 -115.33 REMARK 500 3 GLU A 92 -90.04 -151.86 REMARK 500 3 SER B 3 -65.91 -109.36 REMARK 500 3 LEU B 45 56.02 -115.48 REMARK 500 4 HIS A 28 70.18 57.95 REMARK 500 4 SER A 90 -153.15 45.81 REMARK 500 4 HIS A 91 -67.24 71.04 REMARK 500 4 LYS A 93 -72.24 67.53 REMARK 500 4 LEU A 109 94.38 57.20 REMARK 500 4 HIS B 28 70.26 57.96 REMARK 500 5 MET A 5 175.51 55.77 REMARK 500 5 ALA A 89 85.03 178.44 REMARK 500 5 THR B 2 150.81 59.85 REMARK 500 5 HIS B 91 -162.55 50.56 REMARK 500 6 LEU B 45 64.73 -119.41 REMARK 500 6 GLU B 96 -79.62 65.20 REMARK 500 6 HIS B 104 -157.22 46.29 REMARK 500 7 SER A 3 -153.21 59.06 REMARK 500 7 LYS A 4 -125.56 58.76 REMARK 500 7 LEU A 45 56.67 -116.72 REMARK 500 7 LEU A 86 77.43 -68.73 REMARK 500 7 LEU B 45 57.89 -118.31 REMARK 500 7 LEU B 86 77.08 -68.46 REMARK 500 8 THR A 68 -6.14 -142.42 REMARK 500 8 THR B 68 -5.89 -142.56 REMARK 500 9 LEU A 45 59.13 -115.59 REMARK 500 9 MET B 5 108.98 57.72 REMARK 500 9 LEU B 45 59.54 -116.04 REMARK 500 10 GLU A 96 -86.42 60.76 REMARK 500 10 TRP B 88 -41.17 -161.11 REMARK 500 10 ALA B 89 57.22 72.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 200 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER A 23 O REMARK 620 2 SER A 23 OG 78.4 REMARK 620 3 LEU A 26 O 60.1 138.5 REMARK 620 4 HIS A 28 O 81.3 57.6 111.7 REMARK 620 5 THR A 31 O 145.8 69.8 149.8 71.3 REMARK 620 6 GLU A 36 OE1 116.3 112.9 87.5 159.3 88.3 REMARK 620 7 GLU A 36 OE2 76.1 120.3 52.7 157.1 131.1 42.9 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 201 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 67 OD1 REMARK 620 2 ASN A 69 OD1 106.9 REMARK 620 3 ASP A 71 OD1 62.6 110.5 REMARK 620 4 ASP A 71 OD2 99.3 82.0 41.7 REMARK 620 5 GLN A 73 O 79.6 166.2 61.1 85.0 REMARK 620 6 GLU A 78 OE1 109.8 100.3 149.2 148.4 88.5 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B 202 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER B 23 O REMARK 620 2 SER B 23 OG 78.4 REMARK 620 3 LEU B 26 O 60.0 138.4 REMARK 620 4 HIS B 28 O 81.3 57.7 111.7 REMARK 620 5 THR B 31 O 145.8 69.8 149.9 71.3 REMARK 620 6 GLU B 36 OE1 116.3 112.9 87.5 159.4 88.3 REMARK 620 7 GLU B 36 OE2 76.1 120.1 52.6 157.0 131.2 42.9 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B 201 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 67 OD1 REMARK 620 2 ASN B 69 OD1 107.2 REMARK 620 3 ASP B 71 OD1 62.4 110.4 REMARK 620 4 ASP B 71 OD2 99.3 82.1 41.6 REMARK 620 5 GLN B 73 O 79.3 166.0 61.0 84.7 REMARK 620 6 GLU B 78 OE1 108.9 100.6 149.0 149.3 88.6 REMARK 620 N 1 2 3 4 5 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 31007 RELATED DB: BMRB REMARK 900 EVOLUTION AVOIDS A PATHOLOGICAL STABILIZING INTERACTION IN THE REMARK 900 IMMUNE PROTEIN S100A9 DBREF 7UI5 A 1 114 UNP P06702 S10A9_HUMAN 1 114 DBREF 7UI5 B 1 114 UNP P06702 S10A9_HUMAN 1 114 SEQADV 7UI5 SER A 3 UNP P06702 CYS 3 ENGINEERED MUTATION SEQADV 7UI5 PHE A 63 UNP P06702 MET 63 ENGINEERED MUTATION SEQADV 7UI5 SER B 3 UNP P06702 CYS 3 ENGINEERED MUTATION SEQADV 7UI5 PHE B 63 UNP P06702 MET 63 ENGINEERED MUTATION SEQRES 1 A 114 MET THR SER LYS MET SER GLN LEU GLU ARG ASN ILE GLU SEQRES 2 A 114 THR ILE ILE ASN THR PHE HIS GLN TYR SER VAL LYS LEU SEQRES 3 A 114 GLY HIS PRO ASP THR LEU ASN GLN GLY GLU PHE LYS GLU SEQRES 4 A 114 LEU VAL ARG LYS ASP LEU GLN ASN PHE LEU LYS LYS GLU SEQRES 5 A 114 ASN LYS ASN GLU LYS VAL ILE GLU HIS ILE PHE GLU ASP SEQRES 6 A 114 LEU ASP THR ASN ALA ASP LYS GLN LEU SER PHE GLU GLU SEQRES 7 A 114 PHE ILE MET LEU MET ALA ARG LEU THR TRP ALA SER HIS SEQRES 8 A 114 GLU LYS MET HIS GLU GLY ASP GLU GLY PRO GLY HIS HIS SEQRES 9 A 114 HIS LYS PRO GLY LEU GLY GLU GLY THR PRO SEQRES 1 B 114 MET THR SER LYS MET SER GLN LEU GLU ARG ASN ILE GLU SEQRES 2 B 114 THR ILE ILE ASN THR PHE HIS GLN TYR SER VAL LYS LEU SEQRES 3 B 114 GLY HIS PRO ASP THR LEU ASN GLN GLY GLU PHE LYS GLU SEQRES 4 B 114 LEU VAL ARG LYS ASP LEU GLN ASN PHE LEU LYS LYS GLU SEQRES 5 B 114 ASN LYS ASN GLU LYS VAL ILE GLU HIS ILE PHE GLU ASP SEQRES 6 B 114 LEU ASP THR ASN ALA ASP LYS GLN LEU SER PHE GLU GLU SEQRES 7 B 114 PHE ILE MET LEU MET ALA ARG LEU THR TRP ALA SER HIS SEQRES 8 B 114 GLU LYS MET HIS GLU GLY ASP GLU GLY PRO GLY HIS HIS SEQRES 9 B 114 HIS LYS PRO GLY LEU GLY GLU GLY THR PRO HET CA A 200 1 HET CA A 201 1 HET CA B 201 1 HET CA B 202 1 HETNAM CA CALCIUM ION FORMUL 3 CA 4(CA 2+) HELIX 1 AA1 SER A 6 LEU A 26 1 21 HELIX 2 AA2 ASN A 33 LEU A 45 1 13 HELIX 3 AA3 LEU A 49 ASN A 55 1 7 HELIX 4 AA4 ASN A 55 ASP A 67 1 13 HELIX 5 AA5 SER A 75 TRP A 88 1 14 HELIX 6 AA6 SER B 6 LEU B 26 1 21 HELIX 7 AA7 ASN B 33 LEU B 45 1 13 HELIX 8 AA8 LEU B 49 ASN B 55 1 7 HELIX 9 AA9 ASN B 55 ASP B 67 1 13 HELIX 10 AB1 SER B 75 TRP B 88 1 14 LINK O SER A 23 CA CA A 200 1555 1555 2.54 LINK OG SER A 23 CA CA A 200 1555 1555 2.40 LINK O LEU A 26 CA CA A 200 1555 1555 2.46 LINK O HIS A 28 CA CA A 200 1555 1555 2.75 LINK O THR A 31 CA CA A 200 1555 1555 2.28 LINK OE1 GLU A 36 CA CA A 200 1555 1555 2.75 LINK OE2 GLU A 36 CA CA A 200 1555 1555 3.06 LINK OD1 ASP A 67 CA CA A 201 1555 1555 2.57 LINK OD1 ASN A 69 CA CA A 201 1555 1555 2.77 LINK OD1 ASP A 71 CA CA A 201 1555 1555 2.83 LINK OD2 ASP A 71 CA CA A 201 1555 1555 3.16 LINK O GLN A 73 CA CA A 201 1555 1555 2.60 LINK OE1 GLU A 78 CA CA A 201 1555 1555 2.82 LINK O SER B 23 CA CA B 202 1555 1555 2.54 LINK OG SER B 23 CA CA B 202 1555 1555 2.41 LINK O LEU B 26 CA CA B 202 1555 1555 2.46 LINK O HIS B 28 CA CA B 202 1555 1555 2.75 LINK O THR B 31 CA CA B 202 1555 1555 2.28 LINK OE1 GLU B 36 CA CA B 202 1555 1555 2.75 LINK OE2 GLU B 36 CA CA B 202 1555 1555 3.07 LINK OD1 ASP B 67 CA CA B 201 1555 1555 2.56 LINK OD1 ASN B 69 CA CA B 201 1555 1555 2.77 LINK OD1 ASP B 71 CA CA B 201 1555 1555 2.83 LINK OD2 ASP B 71 CA CA B 201 1555 1555 3.17 LINK O GLN B 73 CA CA B 201 1555 1555 2.63 LINK OE1 GLU B 78 CA CA B 201 1555 1555 2.82 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1